Congress:
ECR24
Poster Number:
C-23936
Type:
EPOS Radiologist (educational)
DOI:
10.26044/ecr2024/C-23936
Authorblock:
J. Goyal, N. Agarwal, P. Garg, S. K. Puri; NEWDELHI/IN
Disclosures:
Jitin Goyal:
Nothing to disclose
Nitin Agarwal:
Nothing to disclose
Prerna Garg:
Nothing to disclose
Sunil Kumar Puri:
Nothing to disclose
Keywords:
Gastrointestinal tract, Oncology, MR, Contrast agent-intravenous, Cancer
- Restaging MRI is a reliable tool in response assessment after neoadjuvant chemoradiotherapy for rectal adenocarcinoma.
- MRI features have been shown to correlate better with pathological response and mrTRG has been an important prognostic factor, associated with tumor recurrence and survival outcomes.